力生制药连收3个涨停板

Group 1 - The stock of Lisheng Pharmaceutical has reached a trading limit, marking three consecutive trading limit increases, with a current price of 26.27 yuan and a turnover rate of 7.22% [2] - During the consecutive trading limit period, the stock has increased by 33.08%, with a cumulative turnover rate of 25.85% [2] - The latest total market capitalization of the A-shares is 6.77 billion yuan, with a circulating market capitalization of 6.58 billion yuan [2] Group 2 - As of July 16, the margin trading balance for the stock is 197 million yuan, with a financing balance of 197 million yuan, reflecting an increase of 9.30 million yuan or 4.94% from the previous trading day [2] - The stock has been listed on the Dragon and Tiger list due to a cumulative deviation of 20% in its price over three consecutive trading days, with institutional net purchases amounting to 16.40 million yuan [2] - The company's Q1 report shows total operating revenue of 370 million yuan, a year-on-year increase of 1.37%, while net profit is 55 million yuan, a year-on-year decrease of 6.56% [2] Group 3 - The company has released a half-year performance forecast, expecting a net profit between 330 million yuan and 355 million yuan, indicating a year-on-year change range of 222.42% to 246.85% [2] - Recent trading performance shows significant daily fluctuations, with the highest daily increase of 10% on July 16 and a net inflow of 40.38 million yuan in main funds [2]